Sputnik V's nasal version registered in Russia
Sputnik V's nasal version registered in Russia
Share:

Sputnik V, the nasal version of Russia's Covid-19 vaccine, has been registered by the Russian Health Ministry as the world's first nasal vaccination against the virus.  Sputnik V posted on Twitter, "Russian Health Ministry registers the nasal version of Sputnik V, the world's first nasal vaccine against Covid-19."

In January, Russian media reported that in three to four months, the nasal vaccine against Covid-19 would be in widespread use and available to Russians.  The Gamaleya Center's Director, Alexander Gintsburg, has previously advised the agency that it would be effective against the new Omicron coronavirus strain.

"Laboratory testing demonstrates that the Sputnik V [coronavirus vaccine] protects against the Omicron (strain) in its conventional injection form, and it will undoubtedly be effective in the nasal form," Gintsburg added. The Gamaleya Center received approval from the Health Ministry for the second phase of clinical testing of the coronavirus vaccine in nasal spray form in October 2021.

Meanwhile, the World Health Organization (WHO) has postponed the review process for granting emergency use authorisation to the Sputnik V vaccination in the aftermath of Russia's invasion of Ukraine, according to a recent report. A WHO official said, the evaluation was postponed since booking flights to Russia is problematic due to Western countries' closure of their airspace to Russian planes following the country's invasion of Ukraine on February 24.

Bharat Biotech to reduce production of Covaxin, explained why

WHO estimates one-third of the world's population yet to get vaccinated

This is the most serious and dangerous symptom of Lassa fever, know treatment for this disease

Join NewsTrack Whatsapp group
Related News